EBV glycoproteins: where are we now?

Area of Science:

• Virology
• Molecular Biology
• Immunology

Background:

• Glycoproteins play essential roles in viral life cycles, including host cell entry and intercellular spread.
• Most viruses possess few glycoproteins, typically located on the virion envelope.
• Epstein-Barr virus (EBV) is a common human herpesvirus with a significant impact on public health.

Purpose of the Study:

• To investigate the diverse roles of Epstein-Barr virus (EBV) glycoproteins in viral pathogenesis.
• To understand how EBV employs multiple glycoproteins for host colonization and immune system modulation.
• To elucidate the mechanisms by which EBV establishes lifelong infections in its human host.

Main Methods:

• Analysis of EBV glycoprotein expression profiles.
• Functional assays to determine the role of specific glycoproteins in cell entry and cell-to-cell spread.
• Studies on the interaction of EBV glycoproteins with host cell receptors and immune components.

Main Results:

• EBV encodes more than 12 distinct glycoproteins, exceeding the number found in many other viruses.
• Specific glycoproteins were identified as crucial for EBV's passage through cell membranes and nuclear targeting.
• Other glycoproteins were found to mediate viral egress from infected cells and facilitate transmission to new hosts.
• Several EBV glycoproteins were shown to actively suppress host immune responses, enabling viral persistence.

Conclusions:

• The extensive repertoire of EBV glycoproteins provides significant functional flexibility for viral colonization and pathogenesis.
• EBV glycoproteins are critical effectors in viral entry, spread, immune evasion, and the establishment of chronic infection.
• Understanding the multifaceted roles of these glycoproteins is essential for developing strategies to control EBV, a ubiquitous human pathogen.